An Exploratory Evaluation of Interleukin 28B (IL28B) Genotype, Single Nucleotide Polymorphisms (SNP) of rs12356193, Protein and RNA Biomarkers in Serum Samples (Stored, Already Obtained From Completed Studies) From Subjects With HBe-antigen Positive or Negative Chronic Hepatitis B, Who Have Completed Therapy for Hepatitis B With Pegasys +/- Lamivudine.
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2014
Price : $35 *
At a glance
- Drugs Lamivudine (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 25 Apr 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 08 Nov 2012 New trial record